SEC Form 4Coverage since Jun 17, 2026
$CRNX insider trading
Over the last 12 months, Crinetics Pharmaceuticals insiders reported no purchases and 2 sales totaling $366K across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $366K 2 events
- Events · 12m
- 2 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $CRNX · 12Mvia TradingView
Top insiders · 12m
Vivaldi Coelho Rogerio—1× · $120K
Okey Stephanie—1× · $246K
All insider trades
2 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Vivaldi Coelho RogerioD | ▼ Sale | 3,000 | $40 | $120K | -13.5% | plan |
| Jun 17, 2026 | Okey StephanieD | ▼ Sale | 6,900 | $35.67 | $246K | -51.9% | plan · 2 tranches |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CRNX feed.